Acute exercise activates AMPK and eNOS in the mouse aorta.

Exercise can prevent endothelial cell (EC) dysfunction and atherosclerosis even in the absence of improvements in plasma lipids. However, the mechanisms responsible for these effects are incompletely understood. In this study we examined in mice whether an acute bout of exercise activates enzymes that could prevent EC dysfunction, such as AMP-activated protein kinase (AMPK) and endothelial nitric oxide synthase (eNOS). We also examined whether exercise alters known regulators of these enzymes. C57BL/6 mice underwent a single bout of exhaustive treadmill exercise after which their aortas were analyzed for activation of AMPK, AMPK regulatory proteins, eNOS, and various enzymes that, like AMPK, activate eNOS. We found that such exercise acutely activates both AMPK and eNOS in the whole aorta and that the magnitude of these effects correlated with both the distance run and activation of the AMPK regulatory proteins silent information regulator-1 (SIRT1)-LKB1 and CaMKKβ. In contrast, Akt, PKA, PKG, and Src, other kinases known to activate eNOS, were unaffected. Immunohistochemical analysis revealed that AMPK and eNOS were both activated in the ECs of the aorta. This study provides the first evidence that an acute bout of exercise activates AMPK and eNOS in the endothelium of the aorta. The results also suggest that AMPK likely is the principal activator of eNOS in this setting and that its own activation may be mediated by both SIRT1-LKB1 and CaMKKβ.

[1]  T. Veenstra,et al.  FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. , 2009, Cell metabolism.

[2]  C. Napoli,et al.  Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases , 2009, Archives of pharmacal research.

[3]  E. Abel,et al.  Endothelial nitric oxide synthase phosphorylation in treadmill‐running mice: role of vascular signalling kinases , 2009, The Journal of physiology.

[4]  B. Fisslthaler,et al.  Activation and signaling by the AMP-activated protein kinase in endothelial cells. , 2009, Circulation research.

[5]  M. Staten,et al.  Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus. , 2009, American journal of physiology. Endocrinology and metabolism.

[6]  H. Nakaya,et al.  Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. , 2009, The American journal of pathology.

[7]  N. Ruderman,et al.  SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1 , 2008, Journal of Biological Chemistry.

[8]  M. Suwa,et al.  Endurance exercise increases the SIRT1 and peroxisome proliferator-activated receptor gamma coactivator-1alpha protein expressions in rat skeletal muscle. , 2008, Metabolism: clinical and experimental.

[9]  S. Douma,et al.  The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease , 2008, BMC cardiovascular disorders.

[10]  J. Connell,et al.  Rosiglitazone Stimulates Nitric Oxide Synthesis in Human Aortic Endothelial Cells via AMP-activated Protein Kinase* , 2008, Journal of Biological Chemistry.

[11]  L. Franco,et al.  Rosiglitazone Reduces Glucose-Induced Oxidative Stress Mediated by NAD(P)H Oxidase via AMPK-Dependent Mechanism , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[12]  J. Balschi,et al.  Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes. , 2007, The Biochemical journal.

[13]  D. Hardie,et al.  AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production , 2007, Biochemical and biophysical research communications.

[14]  D. Power,et al.  Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. , 2007, Journal of molecular and cellular cardiology.

[15]  J. Shyy,et al.  Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo , 2006, Circulation.

[16]  Mengwei Zang,et al.  Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor–Deficient Mice , 2006, Diabetes.

[17]  D. Hardie,et al.  AMP‐activated protein kinase – development of the energy sensor concept , 2006, The Journal of physiology.

[18]  Kei Sakamoto,et al.  LKB1-dependent signaling pathways. , 2006, Annual review of biochemistry.

[19]  Kunihiro Suzuki,et al.  Metformin Inhibits Cytokine-Induced Nuclear Factor &kgr;B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells , 2006, Hypertension.

[20]  Glen P. Kenny,et al.  Physical Activity/Exercise and Type 2 Diabetes , 2006, Diabetes Care.

[21]  T. Garland,et al.  AMP-Activated Protein Kinase Is Involved in Endothelial NO Synthase Activation in Response to Shear Stress , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[22]  R. Busse,et al.  Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells , 2005, Journal of Cell Science.

[23]  N. Ruderman,et al.  Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide. , 2005, Diabetes.

[24]  J. Tuomilehto,et al.  Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. , 2005, Diabetes care.

[25]  G. Watts,et al.  Mechanisms, Significance and Treatment of Vascular Dysfunction in Type 2 Diabetes Mellitus , 2005, Drugs.

[26]  Á. Almeida,et al.  Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective GLUT3-mediated glucose uptake through 5'-AMP-activated protein kinase. , 2004, The Biochemical journal.

[27]  W. G. Wiles,et al.  Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo , 2004, Journal of Biological Chemistry.

[28]  Eric M Isselbacher,et al.  Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. , 2004, Circulation.

[29]  M. Prentki,et al.  AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome , 2004, Nature Reviews Drug Discovery.

[30]  Don P Giddens,et al.  Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. , 2003, American journal of physiology. Heart and circulatory physiology.

[31]  M. Prentki,et al.  AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. , 2003, Acta physiologica Scandinavica.

[32]  D. Hardie,et al.  Management of cellular energy by the AMP‐activated protein kinase system , 2003, FEBS letters.

[33]  D. Harrison,et al.  Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training. , 2003, American journal of physiology. Heart and circulatory physiology.

[34]  S. Kihara,et al.  Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice , 2002, Circulation.

[35]  K. Walsh,et al.  Modulation by Peroxynitrite of Akt- and AMP-activated Kinase-dependent Ser1179 Phosphorylation of Endothelial Nitric Oxide Synthase* , 2002, The Journal of Biological Chemistry.

[36]  A. Koller,et al.  Decreased Arteriolar Sensitivity to Shear Stress in Adult Rats is Reversed by Chronic Exercise Activity , 2002, Microcirculation.

[37]  J. Keaney,et al.  Hydrogen Peroxide Activates Endothelial Nitric-oxide Synthase through Coordinated Phosphorylation and Dephosphorylation via a Phosphoinositide 3-Kinase-dependent Signaling Pathway* , 2002, The Journal of Biological Chemistry.

[38]  I. Shiojima,et al.  Shear Stress Stimulates Phosphorylation of Endothelial Nitric-oxide Synthase at Ser1179 by Akt-independent Mechanisms , 2002, The Journal of Biological Chemistry.

[39]  Paul L Huang,et al.  Accelerated Atherosclerosis, Aortic Aneurysm Formation, and Ischemic Heart Disease in Apolipoprotein E/Endothelial Nitric Oxide Synthase Double-Knockout Mice , 2001, Circulation.

[40]  G. Kojda,et al.  Dysfunctional Regulation of Endothelial Nitric Oxide Synthase (eNOS) Expression in Response to Exercise in Mice Lacking One eNOS Gene , 2001, Circulation.

[41]  D J Campbell,et al.  AMP-activated protein kinase, super metabolic regulator. , 2001, Biochemical Society transactions.

[42]  E. Kraegen,et al.  Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. , 2001, Biochemical Society transactions.

[43]  J. Knowles,et al.  Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. , 2000, The Journal of clinical investigation.

[44]  P. Ortiz de Montellano,et al.  AMP‐activated protein kinase phosphorylation of endothelial NO synthase , 1999, FEBS letters.

[45]  A. Edelman,et al.  Components of a Calmodulin-dependent Protein Kinase Cascade , 1998, The Journal of Biological Chemistry.

[46]  R. Nerem,et al.  Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. , 1998, Circulation research.

[47]  L. Witters,et al.  Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. , 1996, Biochimica et biophysica acta.

[48]  J. Ando,et al.  Cytoplasmic calcium response to fluid shear stress in cultured vascular endothelial cells , 1988, In Vitro Cellular & Developmental Biology.

[49]  P. Kris-Etherton,et al.  Exercise attenuates diet-induced arteriosclerosis in the adult rat. , 1987, The Journal of nutrition.

[50]  G. Heath,et al.  Effects of exercise and lack of exercise on glucose tolerance and insulin sensitivity. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[51]  N. Ruderman,et al.  Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin. , 1982, The Journal of clinical investigation.

[52]  E. Araki,et al.  Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. , 2006, Diabetes.

[53]  D. Carling,et al.  Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. , 2002, Diabetes.